Information on the causes of adult deaths in developing countries is relatively scarce but the subject has received increasing attention in recent years. 1 ' 2 One of the reasons for the scarcity is the difficulty of obtaining population based data on causes of adult deaths. 3 This also applies to HIV associated mortality: notwithstanding the extent of the current epidemic in subSaharan Africa where many AIDS deaths occur at home, observational population based data on HIVassociated mortality are very limited. techniques. This involves the use of structured interviews administered by lay personnel to relatives or friends of the deceased. The technique has so far been used mainly for the ascertainment of causes of childhood deaths in the community, partly to overcome biases associated with hospital registration systems. 6 ' 7 In children, where the range of causes of death is smaller than in adults, VA have been shown to be useful,*"" as they have to a lesser extent, in the assessment of maternal deaths. 12 " 14 We considered that it would be of considerable value if it were possible to estimate the magnitude of the HIV-associated mortality burden in a population without having access to serological data, and the use of VA techniques appeared to be a suitable approach. In this study we have used the VA technique to ascertain whether adult deaths in a rural population cohort were associated with HIV-1 by a comparison of the VA findings with the available HIV-1 serology obtained from annual repeat surveys in the same population.
Study Area and Population
The study area is a cluster of 15 neighbouring villages of a rural subcounty in Masaka district, South West Uganda. The inhabitants, approximately 5000 adults (13+ years) are mainly subsistence fanners who grow bananas and coffee in addition to raising livestock. Medical facilities in the study area were initially limited to two government dispensaries and a mission health centre: a study clinic was set up in late 1990. The nearest hospital is 10 miles from the study area. As in many rural health institutions in developing countries, record keeping is either very poor or non-existent. In cases of death at any of these centres a 'death certificate' may be given which describes the signs and symptoms that led to death but not the cause of death. This is quite often destroyed by the relatives immediately after burial. The centres do not keep any backup documents.
A population cohort, which includes all consenting adults resident in the 15 study villages, was enrolled in 1990 through a census and serological survey. The cohort was kept under surveillance through annual repeat surveys. All sera were tested for HIV-1 antibodies following set algorithms and rigorous quality control procedures using two independent enzyme immunoassay techniques (EIA); Recombigen HIV-1 EIA (Cambridge Biotech Corporation, Worcester, Massachusetts, USA) and Wellcozyme HIV-1 Recombinant (Wellcome Diagnostics, Dartford, UK) and Western blotting (Novopath HIV Immunoblot: Bio-Rad Laboratories, Watford, UK) if the EIA results were discordant or weakly concordant. l5>16 The HIV-1 seroprevalence rate among adults is approximately 8%. Among adults, half of all deaths and among those aged 13-44 over 80% of deaths are attributable to HIV-1 infection. 4 ' 17 
METHODS

Questionnaire Design
A list of indigenous terminology for illnesses and their manifestations as recognized by lay people was constructed using information about common causes of deaths recorded in local hospitals. This list was then incorporated in the design of the VA questionnaire which included the respondents' account of the terminal illness, the interviewer's diagnosis from the elicited history and a list of questions on signs and symptoms, including their presence and duration ( Table 1 ). The questionnaire was translated into the main local language (Luganda) by field staff, and independently back-translated into English by other staff. After modification, the questionnaire was tested in a pilot study so that ambiguous phrasing could be eliminated. In general, the format of the questionnaire followed the VA questionnaire for children developed in The Gambia.
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Procedures for Death Ascertainment and Verbal Autopsies All deaths of adults enrolled into the population cohort during the period December 1990-November 1993 were eligible for VA assessment. These deaths were identified through a monthly village based death registration system that was instituted for this purpose. Annual census data were used to ascertain completeness of monthly system (1% of total deaths). Initially, the household would be visited unannounced by a nurse who would introduce herself, explain the purpose of her visit and administer the questionnaire. Later it was realized that this approach was unsuitable as people sometimes found it difficult to talk about the death of a loved one without time for preparation. This was after interviewing 22 respondents (14% of the total verbal interviews). We consequently modified the procedure after about 6 months and instead started with a condolence visit to the bereaved family made by a counsellor within one month of death. At this visit, the importance of the study was explained to the family and permission requested for a VA interview to be done at a later date. Whenever possible the counsellors also attended the funerals in the area so that they might be seen as part of the community and thus be able to approach the families more easily. Approximately 2 months after the funeral the nurse would interview consenting relative^). However, this period was longer for the extra deaths that were missed by the monthly system and detected by the annual census. We interviewed adult respondents who had cared for the deceased during the terminal illness.
Cause of Death Assessment
At least two clinicians of a panel of four independently assessed each questionnaire and indicated the likely causes of death. None of the clinicians was aware of the HIV-1 status of the deceased. There were no specified criteria given to the clinicians upon which to make the diagnoses. All the assessments were then categorized according to whether HIV/AIDS was mentioned as a likely cause of death. Where the two assessors either disagreed regarding HIV/AIDS as a cause of death or where one could not make a diagnosis due to 'insufficient information', a third clinician made the final decision. 
Data Handling and Analysis
Assessors' diagnoses were entered onto databases using dBase III+ software. HIV-1 serostatus was obtained through linkage with a database of the laboratory results. Cross-tabulations were performed with a statistical package (Epilnfo Version 5.0).
RESULTS
Total Deaths Recorded and VA Assessed by HIV-1 Serostatus
During the study period 293 adult deaths with unequivocal HIV-1 positive or negative serostatus were reported and VA were available for 155 deaths (53%).
Of the remaining deaths, data on VA were not available because the relatives either refused the interview or were absent on three occasions. The age at death and the age distribution of the deaths for which VA assessments were available are shown by HIV-1 serostatus in Table 2 . Overall, half of all recorded deaths were seropositive. Among those aged 13-44 years 75% were seropositive; this compares with 24% among those aged 45 years or more.
Agreement between Assessors
The assessors agreed in 141 (91%) of the 155 deaths whether the cause of death was HIV related or not. The 14 cases with discordant assessments were evenly distributed between those seropositive and seronegative (8 [10%] and 6 [8%] respectively). These 14 cases were classified in accordance with the assessment of a third clinician. The VA classification of the 155 cases is shown in Table 3 by HIV-serostatus and age. In all, 73 (47%) deaths were attributed to HIV-related and 82 (53%) to non HIV-related causes. The six deaths amongst HIV-1 seronegatives which were classified as HIV-related had clinical features of either chest infection or prolonged diarrhoea; whereas the 11 HIV-1 seropositive deaths classified as non HIV-related were either elderly people with non-specific symptoms or young adults who had died from violent causes.
VA Classification and HIV-Serostatus
The performance of the verbal autopsy tool was assessed, using HIV-1 serostatus as a standard of comparison, by calculating the specificity, positive predictive value (PV^) and attributable mortality fraction (AMF).* Since a proportion of HIV-positive subjects are bound to die of non HIV-related causes we considered the sensitivity of the tool less meaningful (particularly in those aged 45 years or more). Moreover from the study design it was not possible to estimate this proportion. Table 4 shows that the overall specificity (71/77) and positive predictive value (67/73) were 92%. In the age group 13-44 years the specificity was (17/20) 85% and the positive predictive value (57/60) 95%. In those aged 45 years or more the corresponding figures were 96% and 77% respectively. The Table also shows HIV attributable mortality fractions comparing VA based estimates with results from the observational cohort study based on HIV serostatus. 17 As shown, the results of both approaches are fairly similar. overall mortality rate -rate in HIV negatives overall mortality rate DISCUSSION The use of the VA technique for ascertainment of causes of adult deaths is relatively new. Chandramohan et al. recently described various factors that influence the validity of the results obtained through the use of this technique and suggested that these include: distinctive features of the fatal disease that can be easily recognized and remembered by lay people, the relative prevalence of the disease, characteristics of the deceased and design and assessment of the questionnaire. 19 A major problem in the development of VA tools has been their validation since both 'gold standards' and reliable clinical data are rarely available in developing country settings. We are aware of only one study where validation of adult verbal autopsy data was carried out using hospital certificates. 20 An alternative approach is the use of surrogate markers but this is suitable only for relatively few causes of death. In the present study we used HIV serostatus as a marker to assess the validity of VA based diagnoses of HIV-associated deaths. Although the agreement between the assessors of non-HIV associated deaths was also high, in the absence of a 'gold standard', some uncertainty remains as to the validity of the individual causes of death.
In the population we studied HIV has become the most common cause of adult death 417 and lay respondents, interviewers and physicians are familiar with the signs and symptoms of HIV associated disease such as chronic fever, chronic diarrhoea, weight loss and herpes zoster. Since AIDS is so common there is consequently a high degree of suspicion. This should in principle contribute to a high sensitivity. However, a respondent closely related to a person who is believed to have died of AIDS may not be prepared to report such manifestations out of fear of possible stigmatization. This may particularly apply when a partner or spouse of a deceased person is interviewed. The high sensitivity observed for the age group 13-44 years (90%) suggests that this possible bias has been minimal.
A high degree of suspicion could on the other hand lead to a loss of specificity as a result of a tendency to classify a death as HIV-associated in cases of diagnostic uncertainty. The age-specific specificity values observed in this study are consistent with this but in view of the high overall specificity the effect appears to be small. In populations with a low prevalence of HIV infection where HIV-associated disease is not well recognized the sensitivity and specificity of the instrument may well be lower than in the present study; in this setting the positive predictive value will be lower.
Data were obtained on about half of all deaths which were recorded during the period of study.
Approximately half of all deaths included in the study were HIV positive. This is very similar to the proportion of HTV positive associated deaths in the cohort study and suggests that a possible HTV-associated selection bias was limited. The HIV-1 serostatus used was that obtained from the most recent annual survey before death. In this way we minimized the possibility of HIV-1 false negative deaths as it would be unlikely that those seroconverting after this would die of HIV-related deaths.
Our results suggest that VA can successfully be used to distinguish, without serological data, between HIV and other causes of death, thus enabling the estimation of the HIV-associated mortality fraction in a population. A paramedic administered the questionnaires which were assessed by clinicians working in a general hospital practice. The staff involved in the study required only a modest amount of training and the overall costs were relatively low.
A number of issues must be borne in mind when conducting similar studies. A check on the accuracy of the data obtained by repeating some of the interviews, as is commonly done with other surveys, is not possible since VA studies are very sensitive and in many areas they are a relatively new method of data collection. As discussed, the prevalence of HIV-1 infection in a population and the resulting rate of HIV-associated deaths may affect the performance of the tool. Culture-specific factors, including disease perceptions, may determine which signs and symptoms of HIV-associated disease are recognized and reported by lay people. As in the present study, the design of the questionnaire must take account of the local terminology for diseases and their manifestations. It is essential that the study procedures are such that confidentiality can be guaranteed and, in view of the possible fear of stigmatization, participants should be assured that strict confidentiality will be maintained. In the present study the process of reassuring participants was initiated by a counsellor during condolence visits to the bereaved families.
We do not know the optimal or longest acceptable recall period, but conducted most of our interviews within about 2 months of death. This interval seemed reasonable in this population as far as recall period was concerned and long enough not to unnecessarily upset those who were close to the deceased.
In conclusion, the results of this study suggest that VA can be used, at relatively low cost, to estimate the HIV-1 associated mortality fraction among adults in general populations with a relatively high prevalence of HIV-1 infection. Such VA studies may improve the availability of data on the magnitude of the burden of HIV and thus assist resource allocation for patient care and the planning of intervention programmes.
